Characterization of C-11 or I-123 labelled β-CIT-FP and β-CIT-FE metabolism measured in monkey and human plasma. Identification of two labelled metabolites with HPLC

Human Psychopharmacology

Volumn 11, Issue 6, 1996, Pages 483-490

  Bergström, Kim A ^a,b   Halldin, Christer ^a   Lundkvist, Camilla ^a   Swahn, Carl Gunnar ^a   Åkerman, Kari K ^b   Kuikka, Jyrki T ^b   Hiltunen, Jukka ^c   Tiihonen, Jari ^d   Länsimies, Esko ^b   Neumeyer, John L ^e   Farde, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c MAP Medical Technologies Oy   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e Research Biochemicals International   (United States)

Author keywords

dopamine transporter; HPLC; metabolism; PET; SPET; CIT; CIT FE; CIT FP

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CARBON 11; DOPAMINE; IODINE 123;

ANIMAL EXPERIMENT; ARTICLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; METABOLISM; MONKEY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 12644291970     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199611)11:6<483::AID-HUP818>3.3.CO;2-0     Document Type: Article

References (24)

1. 123I]N-ω-fluoroalkyl-2β-carboxy-3β-(4-iodophenyl) nortropane esters in baboons. Nuclear Medicine and Biology, 22, 211-219.
2. 123I]β-CIT in human plasma may obstruct quantitation of the dopamine transporter. Synapse, 19, 297-300.
3. Boja, J. W., Kuhar, M. H., Kopajtic, T., Yang, E., Abraham, P., Lewin, A. H. and Carrol, F. I. (1994). Secondary amine analogues of 3β-(4′-substituted phenyl)tropane-2β-carboxylic acid esters and N-norcocaine exhibit enhanced affinity for serotonin and norepinephrine transporters. Journal of Medicinal Chemistry, 37, 1220-1223.
4. 123I]β-CIT. Binding kinetics in the human brain. Journal of Neural Transmission [Gen. Sect.], 94, 137-146.
5. 123.124I]-β-CIT, plasma analysis and pharmacokinetic studies with SPECT and PET [abstract]. VIII. Böttstein colloquium. Workshop of COST-B3-Action on New Radiotracers and Methods of Quality Assurance for Nucleur Medicine Application, October 6/7. Paul Scherrer Institut, Switzerland, Villigen.
6. 11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse, 16, 93-103.
7. 11C]β-CIT-FE, a radioligand for quantitation of dopamine transporters in the living brain using positron emission tomography. Synapse, 22, 386-390.
8. Halldin, C., Swahn, C-G., Farde, L. and Sedvall, G. (1995). Radioligand disposition and metabolism - key information in early drug development. In: PET for Drug Development and Evaluation, Comar, D. (Ed.), Kluwer Dordrecht, The Netherlands, pp. 55-65.
9. Innis, R. B., Seibyl, J. B., Scanley, B. E., Laruelle, M., Abi-Dargham, A., Wallace, E., Baldwin, R. M., Zea-Ponce, Y., Zoghbi, S., Wang, S., Gao, Y., Neumeyer, J. L., Charney, D., Hoffer, P. B. and Marek, K. (1993). Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease. Proceedings of National Academy of Science USA, 90, 11965-11969.
10. Jindall, S. P. and Lutz, T. (1989). Mass spectrometric studies of cocaine disposition in animals and humans using stable isotope-labelled analogues. Journal of Pharmaceutical Sciences, 78, 1009-1014.
11. Kilty, J. E., Lorang, D. and Amara, S. G. (1991). Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science, 254, 578-579.
12. Kuikka, J. T., Åkerman, K., Bergström, K. A., Karhu, J., Hiltunen, J., Haukka, J., Heikkinen, J., Tiihonen, J., Wang, S. and Neumeyer, J. L. (1995b). Iodine-123 labelled N-(2-fluoroethyl)-2β-carbomethoxy-3β-(4-iodophenyl)nortropane (β-CIT-FE) for the dopamine transporter imaging in the living human brain. European Journal of Nuclear Medicine, 22, 682-686.
13. Kuikka, J. T., Bergström, K. A., Ahonen, A., Hiltunen, J., Haukka, J., Länsimies, E., Wang, S and Neumeyer, J. L. (1995a). Comparison of iodine-123 labelled 2β-carbomethoxy-3β-(4-iodophenyl)tropane and 2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-nuoropropyl)-nortropane for imaging of the dopamine transporter in the living human brain. European Journal of Nuclear Medicine, 22, 356-360.
14. 123I]β-CIT) in human brain. European Journal of Nuclear Medicine, 20, 783-786.
15. 11C]β-CIT-FP, a potential PET radioligand for quantitation of the dopamine transporter. Preparation, autoradiography, metabolite studies and PET examinations. Nuclear Medicine and Biology, 22, 905-913.
16. 18F-labelled analogues of β-CIT. Labelling in different positions and PET evaluation in Cynomolgus monkeys. Journal of Labelled Compounds and Radiopharmaceuticals, 37, 52-54.
17. 123I]β-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. American Journal of Psychiatry, 152, 1359-1361.
18. Neumeyer, J. L., Wang, S., Gao, Y., Milius, R. A., Kula, N. S., Campbell, A., Baldessarini, R. J., Zea-Ponce, Y., Baldwin, R. M. and Innis, R. B. (1994). N-ω-Fluoroalkyl analogs of (1R)-2β-carbomethoxy-3j3-(4-iodophenyl)tropane (β-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters. Journal of Medicinal Chemistry, 37, 1558-1561.
19. 123I]-2β-Carbomethoxy-3β-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain. Journal of Medicinal Chemistry, 34, 3144-3146.
20. 123I]β-CIT SPECT. Parkinsonism and Related Disorders, 1, 47-51.
21. Shimada, S., Kitayama, S., Lin, C-L., Patel, A., Nanthakumar, E., Gregor, P., Kuhar, M. and Uhl, G. (1991). Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science, 254, 576-578.
22. 11C]SCH 23390. Identification of two radiolabelled metabolites with HPLC. Human Psychopharmacology, 9, 25-31.
23. 125I-labelled β-CIT and its ω-fluoroalkyl analogues β-CIT-FE and β-CIT-FP including the synthesis of precursors. Journal of Labelled Compounds and Radiopharmaceuticals, 38, 675-685.
24. Tiihonen, J., Kuikka, J., Bergström, K., Hakola, P., Karhu, J., Ryynänen, O-P, and Föhr, J. (1995). Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nature Medicine, 1, 654-657.